Brii Biosciences Limited is a biotechnology company listed on the Hong Kong Stock Exchange, focused on developing innovative therapies for significant public health challenges. The company addresses unmet medical needs, particularly in infectious diseases and central nervous system disorders. With operations in key biotech hubs like Raleigh-Durham, the San Francisco Bay Area, Beijing, and Shanghai...